09 - Appareils et instruments scientifiques et électriques
10 - Appareils et instruments médicaux
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
Produits et services
Personal digital assistants (PDA); Computer operating programs, recorded; Electronic numeric displays; Recorded computer software for database management; Electronic communications systems comprised of computer hardware and recorded software for the transmission of data between two points; Downloadable mobile applications for downloading and reading electronic publications on portable electronic devices; Downloadable computer operating programs; Software as a Medical Device (SaMD), downloadable, for the treatment of diabetes by monitoring glucose levels; Smartwatches; Electronic key fobs being remote control apparatus Probes for medical purposes; Insulin pumps; Carrying case specifically adapted for carrying diabetic supplies, namely, blood glucose meter, testing strips and also including insulin and other related apparatus; Medical diagnostic apparatus for testing blood sugar levels; Glucose meters; Devices for measuring blood sugar; Medical diagnostic apparatus for testing blood sugar levels incorporating recorded operating system software; Medical test kits for diabetes monitoring for home use; Body composition monitors; Medical apparatus for introducing pharmaceutical preparations into the human body Telemedicine services; Provision of medical services by health care professionals via the internet or telecommunication networks; Medical assistance services provided via telecommunication and global computer networks for individuals with health problems through the use of wearable medical devices with automated alert and monitoring capacity; Providing limited in-home personal medical services for individuals including checking vital signs, medication compliance and individual hygiene, checking medical equipment and supplies, and providing on-line information related to these personal medical services; Remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; Providing an internet website for medical professionals and medical patients featuring medical information from remote locations via devices that feed information to the website that is processed, exchanged and accessed in real-time by users; Providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; Medical testing for diagnostic or treatment purposes in the field of diabetes; Medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient; Providing information in the field of diabetes
09 - Appareils et instruments scientifiques et électriques
10 - Appareils et instruments médicaux
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
Produits et services
Computer operating programs, recorded; Computer software, recorded; Electronic publications, downloadable; Computer programs, downloadable; Personal digital assistants [PDA]; Software as a medical device [SaMD], downloadable; Smart watches; Electronic key fobs being remote control apparatus; Electronic numeric displays; Light-emitting electronic pointers; Laptop computers; Tablet computers; Interactive touch screen terminals; Computer software platforms, recorded or downloadable; Wearable computers; Smart glasses; Smart rings; Smartphones; Downloadable application software for virtual environments; Transmitters of electronic signals. Probes for medical purposes; Pumps for medical purposes; Injectors for medical purposes; Medical apparatus and instruments; Glucose meters; Diagnostic apparatus for medical purposes; Testing apparatus for medical purposes; Diabetic monitoring apparatus; Body composition monitors; Trocars; Needles for medical purposes; Hypodermic syringes; Syringes for medical purposes; Medical analysis instruments; Cholesterol meters. Medical clinic services; Rental of sanitary installations; Medical assistance; Telemedicine services; Therapy services; Health counseling; Medical equipment rental; Remote monitoring of medical data for medical diagnosis and treatment; Nutrition and dietetic consultancy; Nursing home services; Health care; Nursing, medical; Medical examination; Mental health services; Sanatorium services; Hospice services; Rest home services; Massage.
3.
CLOSED-LOOP ARTIFICIAL PANCREAS INSULIN INFUSION CONTROL SYSTEM
A closed-loop artificial pancreas insulin infusion control system is provided. The system includes a detection module configured to detect the current blood glucose level G continuously, a program module connected to the detection module and preset with a hybrid artificial pancreas algorithm, used for calculating the insulin infusion amount required by the user, the hybrid artificial pancreas algorithm includes a cPID algorithm and/or a cMPC algorithm, where the input of the cPID algorithm is the intermediate value of the MPC algorithm, and the input of the cMPC algorithm is the output value of the PID algorithm, and an infusion module connected to the program module and controlled by the program module to infuse insulin according to the insulin infusion amount calculated by the hybrid artificial pancreas algorithm.
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
The present invention discloses a body fluid analyte detection device. A sensor is flatly laid on a bottom case. An emitter is detachably connected to the bottom case. After the user mounts the disposable bottom case on the surface of the skin, the reusable emitter is assembled on the bottom case, so as to form the complete analyte detection device. When the user replaces the analyte detection device, the emitter can be separated from the bottom case by simply applying a force to one side of the bottom case and taking the bottom case away from the skin to complete disassembly. The present invention features a simple structure and ease of assembly and disassembly. Since the sensor requires no additional mounting seats, the assembly integration of the emitter, the sensor, and the bottom case is improved, thus making the analyte detection device more compact and enhancing the user experience.
Disclosed in the present invention is a compact body fluid analyte detection device. A transmitter is releasably connected to a bottom shell. After mounting the disposable bottom shell on the surface of the skin, a user assembles the reusable transmitter on the bottom shell, so that a complete analyte detection device can be formed. The transmitter establishes an electrical connection with a sensor by means of a conductive adhesive strip to transmit a signal. A first electrical connection region on the transmitter and an external portion of the sensor are electrically connected to adjacent structural surfaces of the conductive adhesive strip, respectively. The transmitter, the sensor, and the bottom shell can be highly integrated when being assembled together, thereby reducing the overall thickness of the body fluid analyte detection device, such that the analyte detection device is more miniaturized, and the user experience is enhanced.
Disclosed is an analyte detection system. An emitter is detachably connected to a bottom case. After the user installs the disposable bottom case on the surface of the skin through an auxiliary installer, the reusable emitter is assembled to the bottom case, so as to form a complete analyte detection device. Before the bottom case is installed, the bottom case is detachably connected to a parallel sliding block in the auxiliary installer. When the analyte detection device is upgraded, a simple change of the structure of the parallel sliding block may adapt the auxiliary installer to the changes in the size of the bottom case, thereby meeting the version/iteration update requirement of the analyte detection device, and improving the efficiency and cost-efficiency of design and production.
A61B 5/1473 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques invasifs, p. ex. introduits dans le corps par un cathéter
7.
CLOSED-LOOP ARTIFICIAL PANCREAS INSULIN INFUSION CONTROL SYSTEM
The invention discloses a closed-loop artificial pancreas insulin infusion control system, including: a detection module and an infusion module, a detection control unit is set in the detection module, an infusion control unit is set in the infusion module, and at least one calculation control unit is set in the detection module and the infusion module for calculating insulin infusion information and/or further processing of different insulin infusion information. Therefore, the closed-loop artificial pancreas insulin infusion control system can automatically switch the control unit according to different situations to avoid affecting the user experience due to the failure of a module or even bringing safety risks to the user, and to avoid replacing the whole device when only part of the function of some components fails, and to improve the utilization rate of each component of the closed-loop artificial pancreas.
A61M 5/142 - Perfusion sous pression, p. ex. utilisant des pompes
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
8.
CLOSED-LOOP ARTIFICIAL PANCREAS INSULIN INFUSION CONTROL SYSTEM
A closed-loop artificial pancreas insulin infusion control system is provided. The system includes a detection module configured to detect the current blood glucose level G continuously, a program module configured to preset with an rPID algorithm that converts the asymmetric blood glucose in the original physical space to the approximately symmetric blood glucose risk in the risk space and target blood glucose level, and an infusion module which is connected to and controlled by the program module and is configured to infuse insulin according to the corresponding output instructions calculated by the rPID algorithm. The simple and robust characteristics of PID algorithm can be retained, and giving the rPID algorithm the advantages of precision and flexibility, realizing precise control for closed-loop artificial pancreas insulin infusion system.
A61M 5/142 - Perfusion sous pression, p. ex. utilisant des pompes
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
Disclosed in the present invention is a body fluid analyte test device. A transmitter is in releasable connection with a bottom shell. After mounting a disposable bottom shell on the surface of the skin, a user assembles a reusable transmitter on the bottom shell, so that a complete analyte test device can be formed. During the replacement of the analyte test device, the user only needs to apply force to one side of the bottom shell to induce bending failure of the bottom shell and thereby allows the transmitter to be separated from the bottom shell, and then the bottom shell is removed from the skin to complete the disassembly process. A crease groove is formed in the bottom shell, facilitating the bending of the bottom shell. The body fluid analyte test device has a simple structure and is convenient to assemble and disassemble, thereby saving time and labor and enhancing the use experience of users.
A61B 5/1473 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques invasifs, p. ex. introduits dans le corps par un cathéter
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
10.
CLOSED-LOOP ARTIFICIAL PANCREAS INSULIN INFUSION CONTROL SYSTEM
The invention discloses a closed-loop artificial pancreas insulin infusion control system, including: detection module, an infusion module and an electronic module, the detection module, the infusion module and the electronic module all equipped with a control unit, and each control unit is preset with a first algorithm, a second algorithm and a third algorithm correspondingly. When different priority conditions are met, different modules determine the current insulin infusion information. Therefore, the closed-loop artificial pancreas insulin infusion control system can automatically switch control units according to different situations, so as to avoid affecting the user experience and even bringing security risks to users when a module set with the control unit cannot work normally.
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61M 5/168 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
11.
DRUG INFUSION DEVICE WITH INTEGRATED POWER SUPPLY AND ARTIFICIAL PANCREAS
A drug infusion device with integrated power supply includes a drug reservoir, used for accommodating the drug to be infused, provided with a piston and a screw; a driving wheel, connected with the screw, driving the screw to push the piston forward by rotation; a power supply, used to supply power to the infusion device, including a power supply shell, a power supply cell, electrolyte and a cover plate; and a case, including an upper case and a lower case, for accommodating the drug reservoir, the drive wheel and the power supply. The power supply shell is integrated with the lower and/or the cover plate is integrated with the upper case.
H01M 50/124 - Boîtiers primairesFourreaux ou enveloppes caractérisés par le matériau ayant une structure en couches
H01M 50/176 - Dispositions pour introduire des connecteurs électriques dans ou à travers des boîtiers adaptées à la forme des cellules pour des cellules prismatiques ou rectangulaires
H01M 50/186 - Éléments de scellement caractérisés par la position des éléments de scellement
H01M 50/198 - Éléments de scellement caractérisés par le matériau caractérisés par les propriétés physiques, p. ex. adhérence ou dureté
H01M 50/202 - Boîtiers ou cadres autour du boîtier primaire d’une seule cellule ou d’une seule batterie
H01M 50/247 - MonturesBoîtiers secondaires ou cadresBâtis, modules ou blocsDispositifs de suspensionAmortisseursDispositifs de transport ou de manutentionSupports spécialement adaptés aux dispositifs portatifs, p. ex. aux téléphones portables, aux ordinateurs, aux outils à main ou aux stimulateurs cardiaques
H01M 50/271 - Couvercles des boîtiers secondaires, des bâtis ou des blocs
H01M 50/284 - MonturesBoîtiers secondaires ou cadresBâtis, modules ou blocsDispositifs de suspensionAmortisseursDispositifs de transport ou de manutentionSupports comprenant l’insertion de cartes de circuits, p. ex. de cartes de circuits imprimés
The invention discloses the communication system of analyte detection device, which comprises the analyte detection device and the remote equipment. The analyte detection device transmits signals, and the remote equipment is used to search and identify nearby signals, establish the communication connection with the analyte detection device and perform data interaction. The data interaction mode can be adjusted according to the actual use situation, and the battery energy consumption is reduced while transmitting the analyte parameter information, it is conducive to the long-time work of the system and improves the user experience.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance
A calibration free analyte detection device (102, 202, 302) is disclosed. At least one predetermined pair-data set composed of the first parameter value and the second parameter value and the predetermined calibration function based on the time parameter are pre stored in the memory. After a sensor (1022, 2022, 3022) penetrates into the user's skin to obtain the first parameter value, the processor calls the predetermined pair-data set and the predetermined calibration function from the memory and obtains the second parameter value based on the first parameter value by index, the predetermined pair-data set is adjusted through the predetermined calibration function for the next detection and retrieval. The predetermined pair-data set is adjusted with the use time, which reduces the error of the second parameter value and improves the reliability of the analyte detection device (102, 202, 302).
An energy-saving analyte detection system includes an analyte detection device and an auxiliary installer for installing the analyte detection device on the skin surface of a user. The analyte detection device includes a transmitter and a sensor, wherein the transmitter comprises a battery, a wake-up module and a working module. The wake-up module includes a processor, a state switching component and a field effect transistor. Before installation, the state switching component is in an open circuit, the processor is powered on, but is in a deep dormant state, and the field effect transistor is enabled to be in an open circuit; the transmitter does not transmit a signal to the outside. After the analyte detection device is installed, the state switching component is in a closed circuit, the processor is converted into a working state, and the transmitter starts to transmit a signal to the outside.
A highly integrated drug infusion device includes an infusion unit to deliver drugs; a program unit including an input end and an output end, and the input end includes a plurality of electrically connection areas for receiving the signal of analyte data, after the output end is electrically connected to the infusion unit, the program unit controls the drug delivering; an infusion cannula provided with electrodes and electrode contact point; and a conductor, one end is fixed and electrically connected to the electrode contact point, and the other end is slidably and electrically connected to the electrical connection area, when the infusion cannula is installed in the working position, the infusion cannula is connected with the infusion unit, the drug can be injected into the body through the infusion cannula, and the conductor is electrically connected to the electrical connection area, inputting signal of analyte data to the program unit.
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
An installation unit of analyte detection device, includes a housing provided with a slot and a first buckle, the slot includes a first slot point and a second slot point; a parallel slider module provided with a second buckle coupled with the first buckle; a triggering module provide with a lug corresponding to the slot and a fixed buckle corresponding to the first buckle. When the lug is located in the first slot point, the fixed buckle is in contact with the first buckle, and the installation unit does not implement installation action. When the triggering module moves towards the far end relative to the housing, and the lug enters the second slot point, the fixed buckle cancels the contact with the first buckle, and the coupling between the first buckle and the second buckle is released.
Disclosed in the present invention are a closed-loop infusion system and method based on food image recognition. A food image is acquired by an imaging module, and the food image is analyzed by a food image recognition model to obtain food data. An insulin algorithm determines a postprandial insulin infusion amount for a patient on the basis of the food data and simulates postprandial blood glucose for the patient. While infusing insulin, an artificial pancreas collects real-time blood glucose data. The real-time blood glucose data are compared with the simulated blood glucose data, and the comparison result is used for correcting parameters of the insulin algorithm, making the insulin algorithm more suitable for the patient. The present invention improves the accuracy and adaptability of the insulin algorithm, which is conducive to the treatment of diabetes in the patient.
A61M 5/142 - Perfusion sous pression, p. ex. utilisant des pompes
G16H 20/60 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant le contrôle de l’alimentation, p. ex. les régimes
19.
POSTPRANDIAL INSULIN INFUSION SYSTEM AND METHOD BASED ON RECOGNIZABLE FEATURES OF DIABETIC PATIENT
Disclosed are a postprandial insulin infusion system and method based on recognizable features of a diabetic patient. A food image is acquired by an imaging module, and the food image is analyzed by a food image recognition model to obtain food data. According to the recognizable features of the patient, a narrow-sense insulin algorithm adapted to the recognizable features of the patient is retrieved from a narrow-sense insulin algorithm cluster and used for calculating an insulin infusion amount during the meal. Compared with a preset insulin algorithm, the narrow-sense insulin algorithm is more adapted to the physiological characteristics and living habits of the patient, and the calculated postprandial insulin infusion amount is more accurate, which is conducive to the treatment of diabetes in the patient.
A61M 5/142 - Perfusion sous pression, p. ex. utilisant des pompes
G16H 20/60 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant le contrôle de l’alimentation, p. ex. les régimes
20.
METHOD FOR SEARCHING FOR LOST DEVICE, APPLIED TO DIABETES MANAGEMENT SYSTEM
A method for searching for a lost device, applied to a diabetes management system. The diabetes management system comprises at least one wearable medical device, at least one personal management device and one secondary management device, wherein at least one of the personal management device and the secondary management device can be used to control the wearable medical device, and the personal management device is in communication connection with the secondary management device; and when one of the personal management device and the secondary management device is identified as lost, the lost device is searched for by means of the other one of the personal management device and the secondary management device, such that a user can easily find the lost device.
G16H 20/60 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant le contrôle de l’alimentation, p. ex. les régimes
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
H04W 4/02 - Services utilisant des informations de localisation
G08B 21/24 - Alarmes aide-mémoire, p. ex. alarmes contre la perte
An analyte sensor (41) comprises: at least one layer of substrate (411), the substrate (411) comprising an in vivo part and an in vitro part; at least two electrodes (4131, 4231, 4331) arranged on the surface of the in vivo part for penetrating into the subcutaneous to obtain analyte parameter information; and at least two PADs (4111, 4211, 4311) arranged on the surface of the in vitro part and electrically connected with the corresponding electrodes (4131, 4231, 4331) through wires; wherein, each of the electrodes (4131, 4231, 4331) is an array composed of electrode units (4131a, 4231a, 4331a); wherein, at least one layer of insulating material is post manufactured on at least one area of the substrate surface, which avoids the central conductive areas of both the PADs (4111, 4211, 4311) and the electrodes (4131, 4231, 4331).
An analyte sensor (41) comprises: at least one layer of substrate (411), the substrate (411) comprising an in vivo part and an in vitro part; at least two electrodes (4131, 4231, 4331) arranged on the surface of the in vivo part for penetrating into the subcutaneous to obtain analyte parameter information; and at least two PADs (4111, 4211, 4311) arranged on the surface of the in vitro part and electrically connected with the corresponding electrodes (4131, 4231, 4331) through wires (4121, 4221, 4321); wherein, the PADs (4111, 4211, 4311) are respectively located on the opposite side of the in vitro parts; wherein, at least two layers of substrate (411) are combined into a whole by pasting after prefabrication.
An analyte sensor (41) comprises: at least one layer of substrate (411), the substrate (411) comprising an in vivo part and an in vitro part; at least two electrodes (4131, 4231, 4331) arranged on the surface of the in vivo part for penetrating into the subcutaneous to obtain analyte parameter information; and at least two PADs (4111, 4211, 4311) arranged on the surface of the in vitro part and electrically connected with the corresponding electrodes (4131, 4231, 4331) through wires (4121, 4221, 4321); wherein, at least two layers of substrate (411) are combined into a whole by pasting after prefabrication.
A high reliability analyte sensor, in which the electrode is distributed on the surface of the in vivo part in a predetermined manner, avoiding areas easy bending on the substrate. When the substrate is repeatedly bent, the possibility of electrode breakage is reduced, the service life of the sensor is extended, and the detection reliability of the sensor is improved.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
25.
A STRUCTURALLY ENHANCED ANALYTE SENSOR WITH MULTI SUBSTRATE
A structurally enhanced analyte sensor (41) with multi substrate (411a,411b,411d,411e,411f) is disclosed. After the substrate (411a,411b,411d,411e,411f) is prefabricated, it is combined into a whole by pasting, which can avoid insulation failure caused by insufficient solidification of the substrate material, leading to brittle cracking, and further causing crosstalk between electrical signals between wires or electrodes, resulting in noise in the detection signal, at the same time, at least one protective layer (412) is set on the surface of the substrate (411), covering at least the edge of the electrode (4131,4231,4331), increasing the adhesion between the edge of the electrode (4131,4231,4331) and the substrate (411), preventing the edge of the electrode (4131,4231,4331) from curling, bubbling, and detaching. At the same time, the protective layer (412) can also increase the mechanical strength of the substrate (411) of sensor (41), extend the service life of the sensor (41), and improve the detection reliability of the sensor (41).
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
26.
ANALYTE SENSOR WITH DOUBLE-SIDED ELECTRICAL CONNECTION
An analyte sensor (41) comprises: at least one layer of substrate (411), the substrate (411) comprising an in vivo part and an in vitro part; at least two electrodes (4131, 4231, 4331) arranged on the surface of the in vivo part for penetrating into the subcutaneous to obtain analyte parameter information; and at least two PADs (4111, 4211, 4311) arranged on the surface of the in vitro part and electrically connected with the corresponding electrodes (4131, 4231, 4331) through wires; wherein, the PADs (4111, 4211, 4311) are respectively located on the opposite side of the in vitro parts; wherein, at least one protective layer is arranged on the surface of substrate (411), and the protective layer at least covers the edges of the electrodes (4131, 4231, 4331).
An analyte sensor (41) comprises: at least one layer of substrate (411), the substrate (411) comprising an in vivo part and an in vitro part; at least two electrodes (4131, 4231, 4331) arranged on the surface of the in vivo part for penetrating into the subcutaneous to obtain analyte parameter information; and at least two PADs (4111, 4211, 4311) arranged on the surface of the in vitro part and electrically connected with the corresponding electrodes (4131, 4231, 4331) through wires; wherein, each of the electrodes (4131, 4231, 4331) is an array composed of electrode units (4131a, 4231a, 4331a); wherein, at least one protective layer is arranged on the surface of substrate (411), and the protective layer at least covers the edges of the electrodes (4131, 4231, 4331).
A structurally enhanced analyte sensor with multi substrates. After the substrates are prefabricated, they are combined into a whole by pasting, which can avoid the insulation failure caused by brittle crack due to insufficient curing of the substrate material, and further lead to crosstalk between the electrical signals of wires or electrodes, noise in the detection signal, and improve the detection reliability of the sensor, at the same time, at least one layer of insulating material is post manufactured at least one area on the substrate to avoid the area where the PADs and electrodes are located, which increases the mechanical strength of the substrate of sensor. After the sensor is penetrate into the subcutaneous skin, when it bends with the muscle creep, it extends the time for the substrate to reach the limit fatigue, thus prolonging the service life of the sensor and improving the detection reliability of the sensor.
A structurally enhanced analyte sensor (41) is disclosed, which is provided with at least one protective layer (417)on the surface of the substrate (411), which at least covers the edge of the electrode (4131,4231,4331), increases the adhesion between the edge of the electrode (4131,4231,4331) and the substrate (411), and prevents the edge of the electrode (4131,4231,4331) from warping, bubbling and detaching. At the same time, at least one layer of insulating material is post manufactured at least one area on the substrate (411), avoiding the area where the PAD (4111,4211,4311) and electrode (4131,4231,4331) are located, increasing the mechanical strength of the substrate (411) of sensor (41), after the sensor (41) is penetrated into the subcutaneous skin, when it bends with the muscle creep, the time for the substrate (411) to reach the limit fatigue is extended, thus extending the service life of the sensor (41) and improving the detection reliability of the sensor (41).
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
30.
LONG-LIFE ANALYTE SENSOR INTEGRATED WITH TEMPERATURE MEASUREMENT
A long-life analyte sensor (11, 21, 31, 41) integrated with temperature measurement. The sensor comprises at least one substrate (111, 211, 311, 411), at least two electrodes (1131, 1231, 1331, 4131, 2131, 2231, 2331), a pin (1111, 1211, 1311, 1411) and a temperature sensor (1431, 2431), wherein the temperature sensor (1431, 2431) is arranged on a surface of an in-vivo part of the substrate (111, 211, 311, 411), and is used for directly measuring the in-vivo temperature of a patient; and at least one layer of insulating material is arranged behind at least one region (312, 313, 314, 315) of the substrate (111, 211, 311, 411), and avoids a central conductive region in which the pin (1111, 1211, 1311, 1411), the electrodes (1131, 1231, 1331, 4131, 2131, 2231, 2331) and the temperature sensor (1431, 2431) are located.
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
31.
CONTROL SYSTEM FOR BLOOD GLUCOSE MONITORING AND MANAGEMENT
A control system for blood glucose monitoring and management. A first working mode of the control system is to control a blood glucose monitoring device to perform real-time blood glucose monitoring. The control system enters a second working mode on the basis of a trigger condition, and the second working mode at least comprises controlling the blood glucose monitoring device to perform real-time blood glucose monitoring and controlling an insulin infusion device to perform insulin infusion. By means of the trigger condition, the control system enters the second working mode of at least controlling the blood glucose monitoring device to perform real-time blood glucose monitoring and controlling the insulin infusion device to perform insulin infusion from the first working mode of controlling the blood glucose monitoring device to perform real-time blood glucose monitoring, so that a patient is prevented from accidentally entering unnecessary or unauthorized working modes, and the safety of blood glucose monitoring and management of the patient is improved.
A structurally enhanced analyte sensor (11), at least one protective layer (412) is set on the surface of the substrate (411), covering at least a part of the area of the electrode (4131, 4231, 4331), increasing the degree of adhesion between the electrode (4131, 4231, 4331) and the substrate (411), the protective layer (412) can prevent electrode (4131, 4231, 4331) from warping, bubbling, and detaching, extending the service life of the sensor (11), and improving the detection reliability of the sensor (11).
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
33.
ANALYTE SENSOR WITH DOUBLE-SIDED ELECTRICAL CONNECTION
An analyte sensor (41) comprises: at least one layer of substrate (411), the substrate (411) comprising an in vivo part and an in vitro part; at least two electrodes (4131, 4231, 4331) arranged on the surface of the in vivo part for penetrating into the subcutaneous to obtain analyte parameter information; and at least two PADs (4111, 4211, 4311) arranged on the surface of the in vitro part and electrically connected with the corresponding electrodes (4131, 4231, 4331) through wires; wherein, the PADs (4111, 4211, 4311) are respectively located on the opposite side of the in vitro parts.
An analyte sensor (41) comprises: at least one layer of substrate (411), the substrate (411) comprising an in vivo part and an in vitro part; at least two electrodes (4131, 4231, 4331) arranged on the surface of the in vivo part for penetrating into the subcutaneous to obtain analyte parameter information; and at least two PADs (4111, 4211, 4311) arranged on the surface of the in vitro part and electrically connected with the corresponding electrodes (4131, 4231, 4331) through wires; wherein, each of the electrodes (4131, 4231, 4331) is an array composed of electrode units (4131a, 4231a, 4331a); wherein, at least one protective layer is arranged on the surface of substrate (411), and the protective layer at least covers the edges of the electrodes (4131, 4231, 4331).
An analyte sensor (41), comprising at least one layer of substrate (411). The substrate (411)comprises an in vivo part(Y) and an in vitro part(X). At least two electrodes (4131,4231,4331) arranged on the surface of the in vitro part(X) for penetrating into the subcutaneous to obtain analyte parameter information. The electrode (4131,4231,4331) is distributed on the surface of in vivo part(Y) in a predetermined manner, avoiding areas easy to bend on the substrate. When the substrate repeatedly bends, the possibility of the electrode being broken is reduced. At least one protective layer (412) is installed on the surface of the substrate (411), covering at least the edge of the electrode, increasing the adhesion between the edge of the electrode and the substrate, and preventing edge warping, bubbling, and detaching. At the same time, the protective layer (412) can also increase the mechanical strength of the sensor substrate, extend the service life of the sensor, and improve the detection reliability of the sensor.
A61B 5/1473 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques invasifs, p. ex. introduits dans le corps par un cathéter
A structurally enhanced analyte sensor (41) is disclosed, which is equipped with at least one protective layer (412) on the surface of the substrate (411). The protective layer (412) covers at least the edge of the electrode (4131,4231,4331), increases the adhesion between the edge of the electrode (4131,4231,4331) and the substrate (411), prevents the edge of the electrode (4131,4231,4331) from warping, bubbling, and detaching. At the same time, the protective layer (412) can also increase the mechanical strength of the substrate (411) of sensor (41), extend the service life of the sensor (41), and improve the detection reliability of the sensor (41).
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
37.
ANALYTE SENSOR WITH DOUBLE-SIDED ELECTRICAL CONNECTION
An analyte sensor (41) comprises: at least one layer of substrate (411), the substrate (411) comprising an in vivo part and an in vitro part; at least two electrodes (4131, 4231, 4331) arranged on the surface of the in vivo part for penetrating into the subcutaneous to obtain analyte parameter information; and at least two PADs (4111, 4211, 4311) arranged on the surface of the in vitro part and electrically connected with the corresponding electrodes (4131, 4231, 4331) through wires; wherein, the PADs (4111, 4211, 4311) are respectively located on the opposite side of the in vitro parts; wherein, at least one layer of insulating material is post manufactured on at least one area of the substrate surface, which avoids the central conductive areas of both the PADs (4111, 4211, 4311) and the electrodes (4131, 4231, 4331).
An analyte sensor (41), comprising at least one layer of substrate (411). The substrate (411) comprises an in vivo part (Y) and an in vitro part (X). At least two electrodes (4131,4231,4331) arranged on the surface of the in vivo part (Y) for penetrating into the subcutaneous to obtain analyte parameter information. The electrode (4131,4231,4331) is distributed on the surface of the in vivo part (Y) in a predetermined manner, avoiding the easy-bending-area (416) on the substrate. When the substrate is repeatedly bent, the possibility of electrode breaking is reduced. At the same time, at least one layer of insulating material is post manufactured at least one area on the substrate, avoiding the area where the PAD and electrode are located, increasing the mechanical strength of the substrate of sensor. After the sensor is penetrated into the subcutaneous, when bending with muscle peristalsis, the time for the substrate to reach the limit fatigue is extended, thus prolonging the service life of the sensor and improving the detection reliability of the sensor.
A61B 5/1473 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques invasifs, p. ex. introduits dans le corps par un cathéter
A structurally enhanced analyte sensor (41) is disclosed. At least one layer of insulating material is post manufactured at least one area on the substrate (411) to avoid the area where the PADs (4111,4211,4311) and electrodes (4131,4231,4331) are located, which increases the mechanical strength of the substrate (411) of sensor (411). After the sensor (41) is penetrated into the subcutaneous skin, when it bends with the muscle creep, the time for the substrate (411) to reach the limit fatigue is extended, thus extending the service life of the sensor (41), and therefore also improving the detection reliability of the sensor (41).
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
40.
PERSONALIZED CLOSED-LOOP ARTIFICIAL PANCREAS SYSTEM
A personalized closed-loop artificial pancreas system, comprising: a measurement module (100) for continuously measuring the blood glucose level of a patient; an infusion module (102) for infusing insulin into the body of the patient; and a program module (101) for controlling the measurement module (100) and the infusion module (102). At least on the basis of the blood glucose level measured by the measurement module (100), the program module (101) generates an insulin infusion instruction, and controls the infusion module (102) to perform infusion; the program module (101) comprises a user interface; in response to the input of the patient, the program module (101) executes functions of corresponding meal patterns; the meal patterns comprise a high-carbohydrate pattern and a normal-carbohydrate pattern; and on the basis of the input of the patient, the program module (101) executes the function of the high-carbohydrate pattern or the normal-carbohydrate pattern. The present invention can be adapted to people having different carbohydrate consumption habits, improve the adaptability of a closed-loop artificial pancreas to different people, and enable people having different carbohydrate consumption habits to maintain a satisfactory blood glucose control effect.
Disclosed in the present invention is a closed-loop artificial pancreas system, comprising: a measuring module, used for continuously measuring the blood glucose level of a patient; an infusion module, used for infusing insulin into the body of a patient; and a program module, used for controlling the measuring module and the infusion module, wherein at least on the basis of the blood glucose level measured by the measuring module, the program module generates an insulin infusion instruction, and controls the infusion module to perform infusion. The system uses an infusion strategy of pre-infusion and supplemental infusion, the amount of insulin for the pre-infusion is related to an estimated meal size during the pre-infusion, and the amount of insulin for the supplemental infusion is related to an estimated meal size during the supplemental infusion. There is no need to explicitly determine a meal size. On the basis of an estimated meal size, the system determines the amount of insulin to be infused. On one hand, the pressure of needing to accurately determine a meal size is reduced, and on the other hand, considering the dynamic effects of a meal and a high-dose infusion on the blood glucose level, the infusion strategy of pre-infusion and supplemental infusion is used, so that the blood glucose level of a patient is maintained at an ideal level.
Disclosed is a management system for blood sugar monitoring and insulin infusion, comprising at least one wearable medical device, a smart phone on which a dedicated app is installed for controlling the medical device, and a remote server. After the remote server pushes update information to the smart phone, the smart phone controls the wearable medical device to update software or firmware without the need to use more intermediate media to complete updating the medical device, enabling the means of updating the medical device to be more convenient and quick.
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
45.
CLOSED-LOOP ARTIFICIAL PANCREAS SYSTEM FOR SAFE INFUSION
Disclosed in the present invention is a closed-loop artificial pancreas system for safe infusion. During long-time missing of real-time blood glucose value data, on the basis of historical blood glucose values and blood glucose values of fingertips, the closed-loop artificial pancreas system can continue to calculate the infusion amount of insulin required by a patient and infuse a proper amount of insulin into the patient, and will not infuse an improper amount of insulin due to missing of real-time blood glucose value data and even interrupt the infusion of insulin, avoiding the life risk of the patient, and facilitating treatment of the patient.
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
Provided is a diabetes management system used in a hospital. The diabetes management system comprises: at least one wearable medical device which comprises a communication interface used for transmitting and receiving information; a plurality of receivers, wherein any one of the plurality of receivers can be used for receiving and transferring the information sent by the medical device; a central server which comprises a memory and a communication interface, communicates with an external device, and stores the information from the external device; and a medical staff use end device which communicates with the central server and is at least used for displaying or checking medical data information. Any one of the plurality of receivers can receive the medical data sent by the wearable device and upload the medical data to the central server, so that the activity range of patients in the hospital is not limited any more, and medical staff can conveniently and timely acquire the blood glucose level of the patients in real time.
G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance
G01N 33/66 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir les sucres du sang, p. ex. le galactose
H04W 76/14 - Établissement de la connexion en mode direct
H04W 4/80 - Services utilisant la communication de courte portée, p. ex. la communication en champ proche, l'identification par radiofréquence ou la communication à faible consommation d’énergie
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
H04L 67/12 - Protocoles spécialement adaptés aux environnements propriétaires ou de mise en réseau pour un usage spécial, p. ex. les réseaux médicaux, les réseaux de capteurs, les réseaux dans les véhicules ou les réseaux de mesure à distance
47.
BLOOD GLUCOSE MANAGEMENT SYSTEM FOR PROVIDING DATA INTERCOMMUNICATION
Disclosed in the present invention is a blood glucose management system for providing data intercommunication. The system comprises a blood glucose management system used inside a hospital and a blood glucose management system used outside the hospital, wherein a communication connection is established between a central server of the blood glucose management system inside the hospital and a central server of the blood glucose management system outside the hospital, such that missing historical blood glucose data can be complemented each other. When patients are hospitalized and after the patients are discharged from hospital, medical staff, the patients themselves, caregivers or external doctors can obtain complete historical blood glucose records, thereby facilitating the formulation of rapid and effective treatment and rehabilitation plans.
G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance
Disclosed in the present invention is a blood glucose management system used in a hospital. The blood glucose management system comprises: at least one blood glucose monitoring device, which comprises a sensor and a transmitter, wherein the sensor is configured to monitor blood glucose data of a patient in real time, and the transmitter is configured to at least transmit blood glucose data information; a plurality of receivers, any of which may be configured to receive and transfer the information transmitted by the transmitter; a central server, which comprises a memory and a communication interface and is configured to communicate with an external device and store information from the external device; and a medical staff user end device, which is configured to communicate with the central server and display or view the blood glucose data information. Since any of a plurality of receivers can receive blood glucose data monitored by a blood glucose monitoring device and upload same to a central server, the range of motion of a patient in a hospital is not limited any more, and it is also convenient for medical staff to find out the blood glucose level of the patient in a timely manner and in real time.
G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance
49.
ACCOUNT ASSOCIATION METHOD FOR DIABETES MANAGEMENT SYSTEM
Disclosed in the present invention is an account association method for a diabetes management system. Information of a patient account is searched for in other accounts, if the patient account is not present in a patient list of the other accounts, an account association application is sent to the patient account, and upon receiving the account association application, the patient account confirms the account association application, and thus association with the patient account can be realized. For a patient, it is necessary to only confirm the association application, and for other persons, there is no need to jump between different platforms; therefore, the other accounts are associated with the patient account by means of simple operations.
G06Q 10/06 - Ressources, gestion de tâches, des ressources humaines ou de projetsPlanification d’entreprise ou d’organisationModélisation d’entreprise ou d’organisation
G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
An installation unit of analyte detection device, includes: a housing, provided with an auxiliary-needle limit slot; a parallel slider module, the far end face of which is provided with the slider-buckle; an analyte detection device, located at the front end of the parallel slider module; and an auxiliary-needle module. When implementing the installation action, the auxiliary-needle module moves to the near end along with the parallel slider module relative to the housing. The auxiliary-needle inserts the sensor under the skin until the slider-buckle is separated from the auxiliary-needle limit slot, the auxiliary-needle slide block returns back to the initial position, and the auxiliary-needle retracts back into the housing to avoid unnecessary injury. The installation unit has simple structure, high reliability and convenient use.
A closed-loop artificial pancreas insulin infusion control system is provided. The system includes a detection module configured to detect the current blood glucose level continuously, a program module preset with an rMPC algorithm converting the asymmetric blood glucose in the original physical space to the approximately symmetric blood glucose risk in the risk space and target blood glucose level, wherein the rMPC algorithm calculates insulin infusion instructions based on blood glucose risk, and an infusion module connected to the program module and controlled by the program module to infuse insulin according to the corresponding output instructions calculated by the rMPC algorithm. The system is preset with a rMPC algorithm, which converts the asymmetric blood glucose in the original physical space to the approximately symmetric blood glucose risk in the risk space, the recent changes of blood glucose and the asymmetry of distribution are taken into account in the rMPC algorithm.
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
52.
HIGHLY INTEGRATED DRUG INFUSION DEVICE AND ARTIFICIAL PANCREAS
A highly integrated drug infusion device, includes: a drug reservoir, used for accommodating the drug to be infused, provided with a piston and a screw; a driving wheel, connected with the screw, driving the screw to push the piston forward by rotation; a power supply, used to supply power to the infusion device; and a case, including an upper case and a lower case, for accommodating the drug reservoir, the drive wheel and the power supply. A three dimensional circuit is provided on the case, and the three dimensional circuit is electrically connected to the power supply to supply power to the infusion device. The three dimensional circuit is arranged on the case and does not occupy the internal space of the infusion device, which can make the internal arrangement of the infusion device more compact and further reduce the volume of the infusion device.
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
A61M 5/142 - Perfusion sous pression, p. ex. utilisant des pompes
An analyte detection device is provided. A first predetermined pair-data set and a second predetermined pair-data set composed of a first parameter value and a second parameter value are prestored in a memory. The first predetermined pair-data set has at least a time parameter difference relative to the second predetermined pair-data set. After a sensor penetrates a user's skin to obtain the first parameter value, a processor calls the first predetermined pair-data set from the memory in a first time period, and then calls the second predetermined pair-data set from the memory in a second time period, and the second parameter value is obtained based on the first parameter value by index. There is no need for the preset calibration function to calculate the second parameter value according to the first parameter value. Different pair-data sets are called according to the service time of the sensor.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
C12Q 1/00 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions
An installation unit of analyte detection device includes the housing, the protective cover and the label. The protective cover includes an outer cover and an inner cover. The outer ring of the label is fixed on the near end plane of the outer cover, the inner ring is fixed on the near end plane of the inner cover, and the inner ring of the label is connected with the outer ring through the easy tear seam. Before using the installation unit, the outer cover and inner cover remain fixed relative to the housing. When using the installation unit, the inner cover and inner ring of label remain fixed relative to the housing, and the outer cover and outer ring of label rotate relative to the housing to damage the easy tear seam.
B65D 49/12 - Arrangements ou dispositifs pour empêcher le réemplissage des réceptacles par destruction d'une partie du réceptacle par le fait de l'ouvrir
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
An installation unit of an analyte detection device includes a housing. A parallel slider module is arranged inside the housing and can slide relative to the housing. An analyte detection device is arranged at the front end of the parallel slider module. The analyte detection device includes a shell, a transmitter, a sensor and an internal circuit arranged in the shell and electrically coupled with the sensor. The shell connects with the parallel slider module releasably. An auxiliary-needle module is used to pierce the sensor under the use's skin. When a triggering module moves towards the near end relative to the housing, the installation action is implemented. An elastic module is used to provide the elastic force required to implement the installation action.
An analyte detection device with battery and shell integrated is provided. The battery cavity is installed in the outer shell, the battery cavity includes the cavity shell, the diaphragm, the electrolyte, the anode plate, cathode plate and the conductive strip, the electrolyte isolation layer is also arranged inside the cavity shell, to form the structure of battery and outer shell integration, the shape and size of the analyte detection device are no longer limited by the shape and size of the shell of the button battery, and the shape and size of the battery cavity can be optimized according to the miniaturization design requirements of the analyte detection device to improve user experience.
An analyte detection system, includes an auxiliary installer and an analyte detection device, before using, the analyte detection device is in dormant state and transmits signal to the outside equipment at the first frequency, when mounted to the host skin surface by the auxiliary installer, the wake-up module wakes up the analyte detection device according to the triggering conditions, and the analyte detection device enters the working state, transmits signal to the outside equipment at the second frequency, and establishes real-time communication with the outside equipment, the first frequency is less than the second frequency, which can improve user experience while reducing battery energy consumption and ensuring the life of analyte detection device.
A sensor calibration method comprises: providing a lot of sensors which are tested before production to obtain the summary pair-data set Di, classifying and dividing the summary pair-data set to obtain the typical pair-data sets Dj, and storing them in the computer; during production, testing the small number of pair-data of sensors to be delivered, inputting the small number of pair-data into the computer, and obtaining the closest typical pair-data set to the small number of pair-data through calculation, the typical pair-data set can be used as the predetermined pair-data of the sensor to be delivered, and the preset predetermined calibration function is no longer required, which improves the calibration efficiency of the sensor, reduces the production time, and improves the reliability of the sensor.
A61B 5/1495 - Étalonnage ou test des sondes in vivo
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1473 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques invasifs, p. ex. introduits dans le corps par un cathéter
The invention discloses a sensor calibration method, during production, some sample sensors are taken out from a lot of sensors for testing, to obtain the sample pair-data composed of the first test parameter value and the second parameter value. After averaging the first test parameter value, the range value composed of the average first test parameter value of the sample or the average value of the average first test parameter value of adjacent samples is given as the first parameter value of the lot, to obtain the predetermined pair-data set of the lot, and the preset predetermined calibration function is no longer required, which improves the calibration efficiency of sensors, reduces the production time, and improves the reliability of sensors.
An analyte detection device includes an outer shell, a circuit board and a battery cavity. The battery cavity includes a cavity shell, a diaphragm, an electrolyte, an anode plate, a cathode plate and a conductive strip, an electrolyte isolation layer is also arranged inside the cavity shell, an upper cover shell of the cavity shell is integrated with the circuit board. The shape and size of the battery cavity can be optimized according to the miniaturization design requirements of the analyte detection device to improve user experience.
A body fluid analyte detection device includes an analyte detection module for detecting analyte parameter information, and a pasting module. The pasting module includes a tape and a protective film, the first side of the tape is fixedly connected with the analyte detection module, and the second side of the tape is coated with paste material. The protective film is fixed around the outer edge of the first side of the tape, and the outer edge profile of the protective film is compatible with the outer edge profile of the tape, and the rockwell hardness of the protective film is greater than the tape. The protective film can prevent the edge of the tape from warping, avoid displacement or shedding of detection devices when in use, ensure the normal use of the detection device, enhance the user's experience.
A circuit embedded analyte detection device includes a shell, which includes an upper outer shell and a lower outer shell, and a through-hole is arranged on the upper outer shell. The electronic circuit is arranged inside the upper outer shell or the lower outer shell, which includes at least one electronic component. The electronic components include at least a transmitter antenna for communication with external equipment. The sensor is used to obtain the parameter information of analyte in the user's body. A battery is used to power the electronic circuit.
System and method for realizing communication connection of analyte detection device are disclosed. When the communication connection is not established and the communication connection has been established, the analyte detection device transmits two different signals respectively, namely the first signal and the second signal. The remote equipment searches and identifies the nearby signals, and executes different communication connection procedures according to the signals. When only one first signal is recognized by the remote equipment, it can be judged that the analyte detection device transmitting the signal is the analyte detection device to be established with communication connection, and the communication connection can be established directly without the user manually inputting or scanning the equipment code, which simplifies the process of establishing the communication connection, avoids the user inputting or scanning the wrong equipment code, and improves the user experience.
An analyte detection device includes a shell, a sensor, a transmitter, a battery, a memory, and a processor. The sensor includes an internal part and an external part. The internal part is used to penetrate into a user's subcutaneous skin to obtain a first parameter value. At least one predetermined pair-data set composed of the first parameter value and a second parameter value is pre stored in the memory. The second parameter value is associated with the in vivo analyte parameter information. The processor is programmed to call predetermined pair-data set from the memory, and obtain the second parameter value based on the first parameter by indexed. The transmitter is used to transmit the first parameter value and/or the second parameter value to a remote equipment. The battery is used to provide electric energy.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
65.
CALIBRATION METHOD BASED ON PHYSICAL CHARACTERISTICS OF SENSOR
The invention discloses a sensor calibration method. A lot of sensors are tested before production to obtain the summary pair-data set, classify and divide the summary pair-data set to obtain the typical pair-data sets, and store them in the computer. During production, test small number of pair-data of sensors to be delivered, input the small number of pair-data into the computer, and obtain the closest typical pair-data set to the small number of pair-data and difference between them through calculation, and then adjust the closest typical pair-data set based on the difference, and the adjusted typical data set can be used as the predetermined pair-data of the sensor to be delivered, and the preset predetermined calibration function is no longer needed, which improves the calibration efficiency of the sensor, reduces the production time, and reduces the difference between the actual sensitivity of the sensor and the predetermined pair-data.
A61B 5/1495 - Étalonnage ou test des sondes in vivo
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
66.
INSTALLATION UNIT OF ANALYTE DETECTION DEVICE AND USE METHOD
An installation unit of the analyte detection device and use method are provided. The installation unit includes: a housing, including at least two first buckles; a parallel slider module, which is provided with the second buckles corresponding to the first buckles, and the first buckles separately coupled with the second buckles; an analyte detection device; an auxiliary-needle module; an triggering module. When the triggering module moves to the far end relative to the housing, it cancels the coupling of the first buckles and the second buckles to implement the installation action; and an elastic module. When using the installation unit, the user only needs to attach the near end of the installation unit to the skin surface and press the housing at the far end to complete the installation of the analyte detection device, which is simple in structure and convenient in use.
An installation unit of an analyte detection device includes a housing provided with a limit slot. A parallel slider module is provided with a T-shaped structure. The T-shaped structure comprises a horizontal part and a vertical part. The horizontal part includes a T-shaped-structure slider located in the limit slot. An analyte detection device is arranged at the front end of the parallel slider module. The analyte detection device includes a shell, a transmitter, a sensor and an internal circuit arranged in the shell and electrically coupled with the sensor. An auxiliary-needle module is used to pierce the sensor under the use's skin. When a triggering module moves towards the near end relative to the housing, the installation action is implemented. An elastic module is used to provide the elastic force required to implement the installation action.
A miniature analyte detection device, includes a base and at least two electrode groups. The base includes an internal part and an external part. The at least two electrode groups are located on the surface of the internal part, each electrode group includes at least one working electrode and at least one additional electrode. The external part is provided with a PAD corresponding to each electrode, and the PAD is electrically connected with the working electrode and the additional electrode respectively through a wire. The working electrode and the additional electrode are configured to trigger alternately into the working state according to the predetermined conditions when in use, so as to prolong the service life of the sensor, improve the service reliability and enhance the user experience.
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
69.
MICRO ANALYTE SENSOR AND CONTINUOUS ANALYTE MONITORING DEVICE
A micro analyte sensor includes a base that includes an internal part and an internal part. At least one electrode group is located on the surface of the internal part, and each electrode group includes at least one working electrode and at least one additional electrode. The internal part is provided with a pad corresponding to each electrode, and the pad is electrically connected with the working electrode and the additional electrode respectively through a wire. At least one surface of the electronic conduction layer of the working electrode and/or the additional electrode is provided with a micro structure to increase the surface area and roughness of the electronic conduction layer, enhance the adhesion force of the electrode and improve the detection reliability of the sensor.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
70.
MICRO ANALYTE SENSOR AND CONTINUOUS ANALYTE MONITORING DEVICE
A micro analyte sensor includes a substrate, which includes an internal part and an external part; a first electrode group and a second electrode group, located on the surface of the internal part, each electrode group including at least one working electrode and at least one additional electrode. The external part is provided with pins corresponding to each electrode, the pins are respectively electrically connected with the working electrode and the additional electrode through wires. The first electrode group detects the analyte at the first frequency and provides the first detection signal, and the second electrode group detects the analyte at the second frequency and provides the redundant detection signal, and the first frequency is not less than the second frequency.
An analyte detection device with multilayer adhesive tape includes: an analyte detection module fixed on user's skin surface through an adhesive module, the adhesive module equipped with at least N (N≥2) layers of the adhesive tape. The first side of the first layer of the adhesive tape is fixedly connected with the analyte detection module, and the rest of the adhesive tape is stacked on the first side of the first layer of the adhesive tape. The working time of the adhesive module can be extended and the user experience can be improved through relay use of the inner and outer adhesive tape one by one, and the outer adhesive tape delays the edge warping of the inner adhesive tape.
A skin patch drug infusion system includes an infusion mechanism module. The infusion mechanism module includes: a reservoir with a drug inlet and a drug outlet for accommodating the drug to be infused; an infusion needle with one end connected to the drug outlet of the reservoir. The other end is inserted subcutaneously implanting drug infusion. The skin patch drug infusion system includes: a control mechanism module, which works collaboratively with the infusion mechanism module to regulate drug infusion; an adhesive patch that attaches the infusion mechanism module and/or the control mechanism module to the skin surface; a filling module. The drug to be infused into the reservoir is filled via the drug inlet, the volume of the filling module is deliberately designed to be greater than the volume of the drug to be infused to ultimately reduce the risk of air being injected into the body.
A61M 5/142 - Perfusion sous pression, p. ex. utilisant des pompes
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
73.
INTERLOCKING DRUG INFUSION DEVICE AND ARTIFICIAL PANCREAS
An interlocking drug infusion device includes a drug reservoir, used for accommodating the drug to be infused, provided with a piston and a screw; a driving wheel, connected with the screw, driving the screw to push the piston forward by rotation; a driving unit, the driving unit moved in a driving direction to drive the driving wheel to rotate; an actuator, electrically connected to the driving unit, used to provide power for the driving unit in the driving direction after energized; a program module, electrically connected to the actuator, the program module providing a first driving instruction for controlling the actuator to perform periodic power output; and a position detection module, used to determine the periodic drug infusion amount. When the drug infusion amount reaches a preset threshold, the position detection module and/or the program module provide the actuator with a second driving instruction.
A61M 5/14 - Dispositifs de perfusion, p. ex. perfusion par gravitéPerfusion sanguineAccessoires à cet effet
A61M 5/145 - Perfusion sous pression, p. ex. utilisant des pompes utilisant des réservoirs sous pression, p. ex. au moyen de pistons
A61M 5/168 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte
A skin patch drug infusion device includes an infusion mechanism module, a driving unit, a power unit, a control mechanism module, a blockage detection module and an adhesive patch. The infusion mechanism module includes a reservoir used for accommodating the drug to be infused, a screw and a piston connected with the screw arranged inside. The driving unit is provided with driving wheel and driving end. The driving wheel is connected with the screw, and the driving end pushes the driving wheel to make the screw advance in the reservoir. The power unit connected with the driving unit is used for offering power for the driving unit. The control mechanism module is electrically connected with the infusion mechanism module. The blockage detection module operably connected to the control mechanism module includes a detection circuit and at least one detection element.
A61M 5/142 - Perfusion sous pression, p. ex. utilisant des pompes
A61M 5/145 - Perfusion sous pression, p. ex. utilisant des pompes utilisant des réservoirs sous pression, p. ex. au moyen de pistons
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
A skin patch drug infusion device includes an infusion mechanism module, the infusion mechanism module includes: an upper case, a lower case, and a frame. The upper case is provided with multiple upper case engaging portions, and the lower case is provided with multiple lower case engaging portions, the frame is provided with multiple frame engaging portions engaged with the upper case engaging portions and lower case engaging portions; the lower case is further provided with a circuit board, while the circuit board is provided with a plurality of specific connection ends; the frame is provided with electrical connection terminals of specific components, and electrically connected the specific electrical connection ends on the circuit board to realize the internal circuit conduction of the infusion mechanism module. A control mechanism module, is electrically connected with the infusion mechanism module to regulate drug infusion.
An automatic monitoring method based on a rate of change of a difference between actual blood glucose values, and a closed-loop artificial pancreas. The method comprises: acquiring an actual blood glucose value of a user at a current moment (201); acquiring a historical actual blood glucose value of the user at a previous moment, and calculating a difference between the actual blood glucose values at the current moment and the previous moment (202); calculating a rate of change of the difference of the actual blood glucose value at the current moment (203); and comparing the rate of change of the difference of the actual blood glucose value at the current moment with a preset threshold, and determining an event type according to the comparison result. According to the determined event type, the artificial pancreas can automatically adjust a corresponding infusion strategy, thereby achieving closed-loop control of the artificial pancreas.
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
77.
ANALYTE DETECTION DEVICE WITH CIRCUIT BOARD AND SHELL INTEGRATION
An analyte detection device with circuit board and shell integration is provided. An electronic circuit is arranged on the shell of a transmitter module. The electronic circuit includes at least one electronic component. The electronic component at least includes a transmitter antenna to form a highly integrated analyte detection device embedded between the electronic circuit and the shell of the transmitter module. The electronic circuit occupies less space and meets the miniaturization design requirements of the analyte detection device.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
H01M 50/202 - Boîtiers ou cadres autour du boîtier primaire d’une seule cellule ou d’une seule batterie
H01M 50/247 - MonturesBoîtiers secondaires ou cadresBâtis, modules ou blocsDispositifs de suspensionAmortisseursDispositifs de transport ou de manutentionSupports spécialement adaptés aux dispositifs portatifs, p. ex. aux téléphones portables, aux ordinateurs, aux outils à main ou aux stimulateurs cardiaques
78.
DRUG INFUSION DEVICE WITH ELASTIC ANTI-REVERSAL MEMBER
A drug infusion device with elastic anti-reverse member includes an infusion mechanism module, a control mechanism module, and an adhesive patch. The infusion mechanism module includes a reservoir used for accommodating the drug to be infused, a driving wheel assembly, a driving unit with a driving end that pushes the driving wheel to rotate, a power unit and a reset unit. The driving wheel assembly includes a driving wheel, a driving tube and a cover. The cover is used to fix the driving wheel and also provided with at least one elastic member abutting against the driving wheel assembly. The power unit and the reset unit are connected with the driving unit. The power unit exerts a force on the driving unit to make the driving wheel move forward, and the reset unit exerts a force on the driving unit to reset the driving end.
A61M 5/142 - Perfusion sous pression, p. ex. utilisant des pompes
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
A skin patch drug infusion device includes: a control mechanism module and an infusion mechanism module. The infusion mechanism module includes a reservoir, a piston and a screw. A driving unit includes one rotating shaft and at least one driving member, and the driving member includes one driving end, the driving member can rotate around the rotating shaft to advance or reset the driving end. At least one driving wheel is provided with wheel teeth, and the advancing driving end can push the wheel teeth to rotate the driving wheel, thereby driving the screw forward. A linear actuator and a reset unit are respectively connected to the driving member, the linear actuator and the reset unit are respectively apply driving power to the driving member to advance and reset the driving end.
A half-press-free drug infusion device includes a reservoir configured to accommodate the drug to be infused, provided with a piston and a screw; a driving wheel, connected with screw, driving the screw to push the piston forward by rotation; an infusion needle unit, including an infusion needle and an infusion needle holder. The infusion needle holder is used to keep the infusion needle in place, when leaving the factory, the infusion needle unit is at the intermediate position, the infusion needle is communicated with the reservoir. The half-press-free drug infusion device further includes an adhesive patch, for attaching the infusion device module to the skin surface; and security base, arranged on the bottom of the adhesive patch, provided with an infusion needle accommodating part, which is waterproof and breathable.
An analyte detection device with a three-dimensional sensor, includes: a transmitter provided with an electrical connection area; a bottom case provided with a sensor base; a sensor including a signal output end and a detection end. The signal output end is provided with pins, and the detection end is provided with at least two groups of electrodes. The pins are connected with the electrodes through wires, and each group of pins, wires and electrodes are arranged on both sides of an insulating substrate. An elastic conductor includes conductive areas and insulating areas distributed at intervals, and the conductive areas are electrically connected with the electrical connection area. The pins on the first plane of the substrate are electrically connected with the elastic conductor through an external circuit, and the pins on the second plane of the substrate are directly electrically connected with the elastic conductor.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
82.
ANALYTE DETECTION DEVICE WITH CIRCUIT BOARD AND SHELL INTEGRATION
An analyte detection device with circuit board and shell integration is provided, the electronic circuit is arranged on the shell of a transmitter module, the electronic circuit includes at least one electronic component, the electronic component at least includes a transmitter antenna to form a highly integrated analyte detection device embedded between the electronic circuit and the shell of the transmitter module. The electronic circuit occupies less space and meets a miniaturization design requirement of the analyte detection device.
A battery shell integrated analyte detection device is provided, a battery cavity is arranged on the bottom case, the cavity shell is integrated with the bottom case, the diaphragm, the electrolyte, the anode plate, the cathode plate and the pole ear are arranged in the cavity shell, the electrolyte insulation layer is also arranged in the cavity shell, to form the highly integrated analyte detection device with battery and bottom case integration, the shape and size of the analyte detection device are no longer limited by the shape and size of the button battery. After the integration of the battery and bottom case, the battery has more available space and smaller occupied volume, which can meet the design requirements of analyte detection device miniaturization.
H01M 50/247 - MonturesBoîtiers secondaires ou cadresBâtis, modules ou blocsDispositifs de suspensionAmortisseursDispositifs de transport ou de manutentionSupports spécialement adaptés aux dispositifs portatifs, p. ex. aux téléphones portables, aux ordinateurs, aux outils à main ou aux stimulateurs cardiaques
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/1473 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques invasifs, p. ex. introduits dans le corps par un cathéter
H01M 50/202 - Boîtiers ou cadres autour du boîtier primaire d’une seule cellule ou d’une seule batterie
H01M 50/24 - MonturesBoîtiers secondaires ou cadresBâtis, modules ou blocsDispositifs de suspensionAmortisseursDispositifs de transport ou de manutentionSupports caractérisés par les propriétés physiques des boîtiers ou des bâtis, p. ex. dimensions adaptés pour protéger les batteries de leur environnement, p. ex. de la corrosion
An analyte detection device includes: a transmitter provided with electrical connection areas; a bottom case provided with a sensor base; a sensor including a signal output end and a detection end, the signal output end provided with pins, the detection end provided with electrodes, the pins connected with the electrodes through the wires, the pins, the wires and the electrodes arranged on an insulated substrate and located on the same side of the substrate, and the pins facing towards the sensor base; an elastic conductor including conductive areas and insulating areas distributed at intervals, the conductive areas electrically connected with the electrical connection areas, the pins and the elastic conductor electrically connected through an external circuit.
A highly integrated analyte detection device is provided. The device includes a bottom case used for mounting on the surface of human skin; a sensor assembled on the bottom case for detecting analyte parameter information in the user's body; a transmitter module including a shell, a circuit board, a transmitter and an electrical contact, the electrical contact electrically connected with the sensor, the transmitter used to transmit the analyte parameter information to external equipment; and a battery cavity located within the transmitter module. The battery cavity includes a cavity shell, a diaphragm, electrolyte, an anode plate, a cathode plate and a conductive strip. The cavity shell includes an upper cover shell and a lower shell, the upper cover shell is integrated with the circuit board.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
A battery shell integrated analyte detection device is provided. A battery cavity is arranged within the transmitter, and the cavity shell is integrated with the shell of transmitter. The diaphragm, the electrolyte, the anode plate, the cathode plate and the pole ear are arranged in the cavity shell, the electrolyte insulation layer is also arranged in the cavity shell, to form the highly integrated analyte detection device with battery and transmitter integration, the shape and size of the analyte detection device are no longer limited by the shape and size of the button battery. After the integration of the battery and transmitter, the battery has more available space and smaller occupied volume, which can meet the design requirements of analyte detection device miniaturization.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
H01M 50/247 - MonturesBoîtiers secondaires ou cadresBâtis, modules ou blocsDispositifs de suspensionAmortisseursDispositifs de transport ou de manutentionSupports spécialement adaptés aux dispositifs portatifs, p. ex. aux téléphones portables, aux ordinateurs, aux outils à main ou aux stimulateurs cardiaques
H01M 50/271 - Couvercles des boîtiers secondaires, des bâtis ou des blocs
A skin patch drug infusion device includes an infusion mechanism module, provided with multiple first electrical contacts and a first physical component exposed on the surface; a control mechanism module, included a case, and provided with multiple second electrical contacts and an in-position detection module exposed on the surface of the case. The in-position detection module includes a second physical component. When the control mechanism module and the infusion mechanism module are assembled with each other, the first electrical contacts and the corresponding second electrical contacts are squeezed to electrically connect with each other, and the second physical component is operably electrically connected to the first physical component to generate an in-position detection signal.
A61M 5/142 - Perfusion sous pression, p. ex. utilisant des pompes
A61M 5/145 - Perfusion sous pression, p. ex. utilisant des pompes utilisant des réservoirs sous pression, p. ex. au moyen de pistons
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
A drug infusion device with security base includes a reservoir, used for accommodating the drug to be infused, provided with a piston and a screw; a driving wheel, connected with the screw, driving the screw to push the piston forward by rotation; an infusion needle unit, including an infusion needle and a infusion needle holder, the infusion needle holder used to fixedly place the infusion needle; an adhesive patch, for attaching the infusion device module to the skin surface; and a security base, arranged on the bottom of the adhesive patch, provided with an infusion needle accommodating part, for accommodating the infusion needle when the infusion device is priming. The infusion needle accommodating part can accommodate the infusion needle protruding from the adhesive patch, preventing the infusion needle from stabbing the user.
A61M 5/142 - Perfusion sous pression, p. ex. utilisant des pompes
A61M 5/145 - Perfusion sous pression, p. ex. utilisant des pompes utilisant des réservoirs sous pression, p. ex. au moyen de pistons
A61M 5/168 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
A skin patch drug infusion device is disclosed. The skin patch drug infusion device includes an infusion mechanism module, the infusion mechanism module includes an infusion module and a circuit module, the circuit module includes: a circuit board or a three-dimensional circuit coated on the surface of part components, for supplying power to specific units; a power supply, for supplying power to the infusion device; an elastic conductor, provided with at least a protrusion, for electrically connecting the power supply to the specific connection end on the circuit board or three-dimensional circuit; a control mechanism module, electrically connected with the infusion mechanism module; and an adhesive patch, for attaching the infusion mechanism module and the control mechanism module to the skin surface. The elastic conductor is provided with protrusions.
Provided is an installation unit (100) of an analyte detection apparatus (104). A buckle structure of a parallel slider module (103) is in contact with an annular structure of the analyte detection apparatus (104), so that releasable connection is formed between the parallel slider module (103) and the analyte detection apparatus (104); when the parallel slider module (103) is located at a distal end, the analyte detection apparatus (104) is fixed on the parallel slider module (103), and after the parallel slider module (103) slides to a proximal end, the analyte detection apparatus (104) is automatically separated from the parallel slider module (103). The installation unit (100) features simple structure and high reliability and is convenient to use.
Provided is a drug infusion system with a graphical user interface, which comprises a detection apparatus (100), an infusion apparatus (102), and a control apparatus (101). The detection apparatus (100) is used for detecting a blood glucose value of a user, the infusion apparatus is used for infusing a drug into a user, and the control apparatus (101) is in wireless communication with the detection apparatus (100) and the infusion apparatus (102), and the control apparatus (101) controls drug delivery of the infusion apparatus (102). The control apparatus (101) is provided with a graphical user interface comprising a main screen, and the main screen comprises an insulin information display area and a blood glucose information display area. The insulin information display area comprises insulin infusion state information, and the user interface displays the insulin infusion state information in the form of a pattern (2021) and/or a text (2022). A user can visually know current insulin infusion state information and blood glucose information.
A61M 5/142 - Perfusion sous pression, p. ex. utilisant des pompes
G16H 40/60 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
94.
MANAGEMENT DEVICE AND METHOD FOR DISPLAYING GLUCOSE INFORMATION
A management device for displaying glucose information. The screen of the management device is divided into the plurality of display areas, at least comprising a first display area for displaying the status of the management device, a second display area for displaying real-time glucose information, and a third display area for displaying historical glucose concentration information. The user can intuitively and easily get the glucose information in the body.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
A skin patch drug infusion device includes an infusion mechanism module, the infusion mechanism module includes a reservoir, used for accommodating the drug to be infused, a screw and a piston connected with the screw are arranged inside; a driving wheel assembly, threadedly connected with the screw, wherein the driving wheel assembly includes a driving wheel body and a movable block, the driving wheel body and the movable block are operatively connected, when the movable block is in opened, the screw does not engage with the driving wheel assembly, and when the movable block is closed, the screw engages with the driving wheel assembly. The infusion mechanism module further includes a control mechanism module, electrically connected with the infusion mechanism module; and an adhesive patch, for attaching the infusion mechanism module and the control mechanism module to the skin surface.
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
A skin patch drug infusion device is provided. The device includes an infusion mechanism module, a control mechanism module and an adhesive patch. The infusion mechanism module includes an infusion module and a circuit module. The circuit module includes: a circuit board or a three-dimensional circuit coated on the surface of part components, for supplying power to specific units; a driving unit, for pushing the driving wheel of the infusion mechanism module to implement drug infusion; a conductive tower-spring, including a middle part with a small diameter and two end parts with a large diameter in the axial direction, for fixing the driving unit and electrically connecting the driving unit and the specific connection end on the circuit board or three-dimensional circuit. The control mechanism module is electrically connected with the infusion mechanism module. The adhesive patch is used for attaching the infusion mechanism module and the control mechanism module to the skin surface.
A drug infusion device with embedded power supply includes a drug reservoir, used for accommodating the drug to be infused, provided with a piston and a screw; a driving wheel, connected with the screw, driving the screw to push the piston forward by rotation; a power supply, used to supply power to the infusion device, including a power supply shell, a battery cell, electrolyte and a cover plate; a frame, used to carry the drug reservoir, the driving wheel, the power supply and electrical connection terminals of specific components, the power supply is electrically connected to the electrical connection terminals of specific components to realize power supply to the infusion device; a case, including an upper case and a lower case, for accommodating the drug reservoir, the driving wheel, the power supply and frame.
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
A61M 5/142 - Perfusion sous pression, p. ex. utilisant des pompes
A skin patch drug infusion device includes an infusion mechanism module, the infusion mechanism module includes an infusion module and a circuit module, the circuit module includes: a circuit board or a three-dimensional circuit coated on the surface of part components, for supplying power to specific units; a power unit, for providing power to pull the driving wheel of the infusion mechanism module to implement drug infusion; a conductive platform, provided with a conductive platform protrusion, for electrically connecting the power unit to the specific connection end on the circuit board or three-dimensional circuit; a control mechanism module, electrically connected with the infusion mechanism module; and an adhesive patch, for attaching the infusion mechanism module and the control mechanism module to the skin surface.
A61M 5/142 - Perfusion sous pression, p. ex. utilisant des pompes
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
An integrated skin patch artificial pancreas includes an infusion mechanism module, including a case, provided with multiple second electrical contacts exposed on the case and multiple second engaging portions; a control mechanism module, provided with multiple first electrical contacts exposed on the surface of the control mechanism module and multiple first engaging portions, the control mechanism module including an input end and an output end, and the input end including electrically connective regions for receiving signals of analyte data in the body fluid and an infusion tube (150), provided with multiple electrodes.
A61M 5/142 - Perfusion sous pression, p. ex. utilisant des pompes
A61M 5/14 - Dispositifs de perfusion, p. ex. perfusion par gravitéPerfusion sanguineAccessoires à cet effet
A61M 5/145 - Perfusion sous pression, p. ex. utilisant des pompes utilisant des réservoirs sous pression, p. ex. au moyen de pistons
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques